December 17, 2014
Michael Pearlmutter
Partnership for Clean Competition
Executive Director


COLORADO SPRINGS, Colo. – The Partnership for Clean Competition (PCC), announced today that it awarded four new grants in support of research designed to advance and improve the ability to detect and deter the use of substances and methods prohibited in sport.

“These grants will help us tackle significant problems related to performance enhancing drugs, including blood doping and peptide use,” said PCC Executive Director Michael Pearlmutter. “The researchers are doing important work that will directly result in improved detection in a variety of areas critical to anti-doping.”

The recipients of this most recent round of funding, which was approved recently by the PCC Board of Governors, represent research institutions in both North America and Europe:

  • Dr. David Chen at the University of British Columbia for his work entitled “Capillary Electrophoresis-Mass Spectrometry Glycoscreening for Detection of Doping.”
  • Dr. Daniel Eichner at Sports Medicine Research & Testing Laboratory for his work entitled “Evaluating Hepcidin as a Biomarker of Blood Doping.”
  • Dr. Daniel Eichner, Dr. John Higgins, and Dr. Jaime Watkins at Sports Medicine Research & Testing Laboratory and Massachusetts General Hospital for their work entitled “Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling.”
  • Dr. Peter Van Eenoo at the Doping Control Laboratory at Ghent University for his work entitled “Detection of new Rev-erbα agonist as potential doping agents: SR9009 and SR9011.”

Since 2008, the PCC has awarded more than $12 million in research grants to advance the anti-doping movement. With this round of funding announced, PCC has far exceeded its 2013 funding totals. ​

The PCC is already accepting applications for grants and fellowships for the first funding round in 2015. Pre-applications are due on March 1, with full applications due a month later for those whose pre-applications are accepted. Funding decisions are made within eight weeks and, since 2008, have ranged from $10,000 to more than $400,000, depending on the nature of the research and the funding needed. To learn more about PCC’s research, including how to apply for a grant, please visit


About the Partnership for Clean Competition

The Partnership for Clean Competition is an innovative research collaborative founded in 2008 as a 501(c)(3) non-profit public charity by the United States Olympic Committee, United States Anti-Doping Agency, Major League Baseball and the National Football League. Every day, the PCC acts to protect the integrity of sport and public health by engaging and supporting the world’s top scientists and innovators in high-quality anti-doping research and development. The PCC also facilitates adoption of these methods into the World Anti-Doping Agency-accredited laboratories. The PCC aspires to help generate the world’s most influential, effective and coveted methods and resources for detecting and deterring the use of performance enhancing substances by all athletes in all sports at all levels. Through this work, the PCC demonstrates the value of science, collaboration and innovation related to doping control in sport and ensures the benefits of sport participation. For more information, visit ​